Pregabalin and Deafness unilateral - a phase IV clinical study of FDA data

Summary:

Deafness unilateral is reported as a side effect among people who take Pregabalin (pregabalin), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Paracetamol, and have Depression.

The phase IV clinical study analyzes which people have Deafness unilateral when taking Pregabalin. It is created by eHealthMe based on reports of 73,056 people who have side effects when taking Pregabalin from the FDA, and is updated regularly.

What is Pregabalin?

Pregabalin has active ingredients of pregabalin. It is often used in fibromyalgia. eHealthMe is studying from 74,070 Pregabalin users. Check the latest studies of Pregabalin.

What is Deafness unilateral?

Deafness unilateral is found to be associated with 493 drugs and 1,084 conditions by eHealthMe. Check the latest studies of Deafness unilateral.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 29, 2026

73,056 people reported to have side effects when taking Pregabalin.
Among them, 28 people (0.04%) have Deafness unilateral.

Could Pregabalin cause Deafness unilateral?

Among these 28 people:

How long have people been on Pregabalin when they have Deafness unilateral? *

What is the gender of people who have Deafness unilateral when taking Pregabalin? *

female: 57.69 %
male: 42.31 %

What is the age of people who have Deafness unilateral when taking Pregabalin? *

What are other drugs people take besides Pregabalin? *

Paracetamol: 7 people, 25.00%
Fragmin: 4 people, 14.29%
Macitentan: 4 people, 14.29%
Epoprostenol Sodium: 4 people, 14.29%
Adcirca: 4 people, 14.29%
Escitalopram: 4 people, 14.29%
Furosemide: 4 people, 14.29%
Norco: 2 people, 7.14%
Oxycodone And Acetaminophen: 2 people, 7.14%
Novolog: 2 people, 7.14%

What are other side effects people have besides Deafness unilateral? *

Head Injury: 12 people, 42.86%
Memory Loss: 11 people, 39.29%
Nausea And Vomiting: 10 people, 35.71%
Dyspnea (difficult or laboured breathing): 9 people, 32.14%
Disturbance In Attention: 9 people, 32.14%
Dizziness: 9 people, 32.14%
Fatigue (feeling of tiredness): 9 people, 32.14%
Agoraphobia (extreme or irrational fear of crowded spaces or enclosed public places): 8 people, 28.57%
Libido Decreased (loss of interest in sex): 8 people, 28.57%
Heart Rate Increased: 8 people, 28.57%

What are the existing conditions these people have? *

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 4 people, 14.29%
Depression: 4 people, 14.29%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 3 people, 10.71%
Osteoporosis (bones weak and more likely to break): 3 people, 10.71%
Osteoporotic Fracture (fracture due to weak bone): 2 people, 7.14%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 7.14%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 7.14%
Ankylosing Spondylitis (type of arthritis affecting the spine): 2 people, 7.14%
Type 2 Diabetes: 1 person, 3.57%
Transitional Cell Carcinoma (cancer tumour inner most layer of urinary system): 1 person, 3.57%

* Approximation only. Some reports may have incomplete information.

Do you take Pregabalin and have Deafness unilateral?

- Check whether Deafness unilateral is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pregabalin:

Pregabalin (74,070 reports)

Browse all side effects of Pregabalin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Deafness unilateral:

Deafness unilateral (493 drugs)

Browse all the conditions that are associated with Deafness unilateral:

Deafness unilateral (1,084 conditions)

Related publications that referenced our studies

de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
Bonnet U, Taazimi B, Grabbe HD, "Pregabalin-Related Hypertriglyceridemia", Psychosomatics, 2014 Nov .
de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
Bonnet U, Taazimi B, Grabbe HD, "Pregabalin-Related Hypertriglyceridemia", Psychosomatics, 2014 Nov .

How the study uses the data?

The study uses data from the FDA. It is based on pregabalin (the active ingredients of Pregabalin) and Pregabalin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.